Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E M Griffiths

Showing results (271-280 of 337) with videos related to

Pageof 34
Sort By:
The Journal of Dermatological Treatment|July 19, 2014
A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in childrenJohn Berth-Jones, Ian Pollock, Ross M R Hearn, et al.
The Journal of Investigative Dermatology|August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort StudyNina Wilkinson, Teresa Tsakok, Nick Dand, et al.
Frontiers in Immunology|September 19, 2025
Mesenchymal stromal cells as rescue therapy in biologic-refractory psoriasis: insights from a case seriesSu M Lwin, Shane Solanky, Cristiano Scottà, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 5, 2024
The epidemiology of atopic dermatitis and psoriasis in the indigenous people of BrazilDébora D B C Andrade, Reagan Nzundu, Rodolfo R D Rodrigues, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 11, 2010
Tissue section AFM: In situ ultrastructural imaging of native biomoleculesHelen K Graham, Nigel W Hodson, Judith A Hoyland, et al.
Dermatology and Therapy|November 22, 2019
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of ExposureApril Armstrong, Carle Paul, Luis Puig, et al.
The Journal of Investigative Dermatology|March 29, 2025
Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with BiologicsAli Al-Janabi, Paul Martin, Catherine Simpson, et al.
The Journal of Investigative Dermatology|June 9, 2015
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Richard B Warren, Catherine H Smith, Zenas Z N Yiu, et al.
International Journal of Dermatology|January 31, 2025
Psoriasis in People With Skin of Color: An Evidence-Based UpdateMaria-Angeliki Gkini, Mio Nakamura, Andrew F Alexis, et al.
Acta Dermato-Venereologica|November 20, 2019
Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease RiskC Elise Kleyn, Peter S Talbot, Nehal N Mehta, et al.
Pageof 34

Showing results (271-280 of 337) with videos related to

Sort By:
Pageof 34
The Journal of Dermatological Treatment|July 19, 2014
A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in childrenJohn Berth-Jones, Ian Pollock, Ross M R Hearn, et al.
The Journal of Investigative Dermatology|August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort StudyNina Wilkinson, Teresa Tsakok, Nick Dand, et al.
Frontiers in Immunology|September 19, 2025
Mesenchymal stromal cells as rescue therapy in biologic-refractory psoriasis: insights from a case seriesSu M Lwin, Shane Solanky, Cristiano Scottà, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 5, 2024
The epidemiology of atopic dermatitis and psoriasis in the indigenous people of BrazilDébora D B C Andrade, Reagan Nzundu, Rodolfo R D Rodrigues, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 11, 2010
Tissue section AFM: In situ ultrastructural imaging of native biomoleculesHelen K Graham, Nigel W Hodson, Judith A Hoyland, et al.
Dermatology and Therapy|November 22, 2019
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of ExposureApril Armstrong, Carle Paul, Luis Puig, et al.
The Journal of Investigative Dermatology|March 29, 2025
Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with BiologicsAli Al-Janabi, Paul Martin, Catherine Simpson, et al.
The Journal of Investigative Dermatology|June 9, 2015
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Richard B Warren, Catherine H Smith, Zenas Z N Yiu, et al.
International Journal of Dermatology|January 31, 2025
Psoriasis in People With Skin of Color: An Evidence-Based UpdateMaria-Angeliki Gkini, Mio Nakamura, Andrew F Alexis, et al.
Acta Dermato-Venereologica|November 20, 2019
Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease RiskC Elise Kleyn, Peter S Talbot, Nehal N Mehta, et al.
Pageof 34